Abstract:AIM To evaluate the efficacy and safety of compound famotidine chewable tablets in treatment of symptoms of heartburn,sour regurgitation due to acid-related disorders.METHODS It was a randomized,double- blind,active controlled and multi-center study.A total of 240 proper patients were randomized to enter either compound famotidine chewable tablet group(group A) or active drug famotidine group(group B) in 1∶1 ratio.Patients in group A took one famotidine placebo capsule first,then took one compound famotidine chewable tablet when having symptoms. Patients in group B took one famotidine capsule first,then took one compound famotidine placebo chewable tablet when having symptoms.Patients in both groups took study drugs before sleeping if the patients had no symptoms.Daily test drug and active controlled drug were not allowed to more than two.The course was 7 d.Symptoms of heartburn,sour regurgitation and upper abdominal pain should be evaluated before treatment and everyday after treatment.Symptoms were evaluated in 5,10,15,20,30,40,50,60 and 120 min after every drug administration.RESULTS A total of 227 patients completed the study according to the protocol,including 114 in group A and 113 in group B.In the first day,instant remission rate of heartburn in group A 10 and 15 min after drug administration was 31.63%and 44.90%respectively, which was significantly higher than group B(P values were 0.006 7 and 0.037 0,respectively).Instant remission rate of sour regurgitation and upper abdominal pain in group A in every time spot within 10-60 min after drug administration was significantly higher than group B,respectively(P values were all less than 0.05).Instant remission rate of overall symptoms in group A 5 min after drug administration was 17.70%.Instant remission rate in every time spot till 60 min after drug administration was significantly higher than group B(P values were all less than 0.05).Instant remission rate of every symptom in 2nd day to 7th day similar to 1st day.Complete remission time in group A for all symptoms was within 50 min.Complete remission time was(46.57±27.39) and(40.95±22.02) min in 1st day and 2nd day,respectively, which was significantly faster than group B(P values were 0.010 6 and 0.006 2,respectively).There were 7 adverse events found in this study,all in group B.No adverse events were found in group A.CONCLUSION Compound famotidine chewable tablet can result in faster remission of symptoms of heartburn,sour regurgitation and upper abdominal pain due to acid-related disordersas compared with famotidine.

The frequency of oral famotidine administration influences its effect on gastric pH in cats over time

Comparative analysis of the effect of PO administered acid suppressants on gastric pH in healthy cats

Evaluation of the effect of a famotidine continuous rate infusion on intragastric pH in healthy dogs

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs

Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH

Evaluation of Gastric pH and Serum Gastrin Concentrations in Cats with Chronic Kidney Disease

The effect of concurrent clopidogrel and omeprazole administration on clopidogrel metabolism and platelet function in healthy cats

Pharmacokinetics of Compound Famotidine Chewable Tablets in Healthy Volunteers

Rational use of gastroprotectants in cats: An evidence-based approach

The effect of pre-anaesthetic fasting time and type of food on gastric content volume and acidity in dogs

The effect of once daily omeprazole and succinic acid (VECAM) vs once daily omeprazole on 24-h intragastric pH

115 Effects of Probiotic and Heat-Killed Probiotic Supplementation on Systemic Biomarkers of Oxidative Stress and Inflammation and Fermentative end Products of Adult Cats

Evaluation of the effects of medium‐term (57‐day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse

Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies

203 The Effects of Daily Supplementation of Selected Probiotic and Postbiotic on the Microbiome of Adult Cats

Prevalence and appropriateness of omeprazole prescription in dogs at a veterinary teaching hospital before and after the publication of the ACVIM consensus statement on the rational administration of gastrointestinal protectants

Efficacy of oral AB070597 for the management of chronic kidney disease in cats: a prospective, randomised, controlled parallel-group study

Effect of aluminum hydroxide on serum phosphate and fibroblast growth factor 23 concentrations in young adult cats with surgically induced chronic kidney disease

Effects of Heat-Treated Bifidobacterium longum CECT-7384 Combined with Fibersol-2 on the Intestinal Health of Cats Submitted to an Abrupt Dietary Change: A Randomized Controlled Study

Compound Famotidine Chewable Tablets in Treatment of Symptoms of Heartburn,sour Regurgitation Due to Acid-Related Disorders: a Randomized, Double-Blind, Active Controlled, Multi-Center Study

Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy